Oncogarde is an AI-driven healthcare app designed for oncology clinics, combining data from EHRs, labs, and insurers to detect dangerous drug and genetic risks instantly. Built using the latest AI development practices, it delivers real-time alerts and plain-language explanations—all in one clean dashboard.
Pharmacists spend up to 45 minutes per oncology patient, checking as many as 11 drugs across scattered EHR, PGx, and interaction sources. This manual process increases the risk of missing dangerous drug or gene conflicts.
When chemo dose changes or PGx factors aren’t coded exactly, 10–15% of claims are denied—slowing revenue, increasing staff workload, and leaving patients with surprise bills.
Merges EHR meds, PGx results, and RxNorm data into one graph-based AI model that flags high-risk drug–gene interactions in seconds.
Cross-checks every prescribed drug against PGx data in the EHR, replacing time-consuming manual reviews.
Delivers clear warnings to doctors and pharmacists about dangerous combinations before any infusion starts.
Gives clinicians a live risk queue and finance teams KPI insights in one cloud platform with a full audit trail.
Ptolemay Company is powered by a team of over 50 highly specialized experts, including an advanced development crew.
.png)
.png)
.png)